Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Significance: Primary effusion lymphoma (PEL) is a B cell lymphoma; the prognosis is poor, with a median survival around 6 months. PEL is always associated with the presence of Kaposi’s sarcoma-associated herpesvirus and in most cases is coinfected with Epstein–Barr virus (EBV); however, the role of EBV in the pathogenesis of the tumor is still not clear. This study demonstrates the intricate interaction between the two herpesviruses, which exacerbate tumorigenesis by mutually reinforcing the persistence of each latent genome and by altering cell proliferation. It establishes curing EBV and inhibiting Epstein–Barr nuclear antigen 1 as a potential treatment for PEL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it took at least 5 days to prepare and verify the recombinant plasmids.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition
Ren, J., Liu, X., Fang, C., Jiang, S., June, C. H., & Zhao, Y. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1300 · Cited by 942
RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection
Wang, J., & Quake, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410785111 · Cited by 220 · cited 16×
“EBV-specific CRISPR/Cas9 plasmids were obtained from S. Quake (Stanford University, Stanford, CA).”
BackgroundMethodInfluential
Research works printed but not linked: 67
- 10.1080/17474086.2017.1326815 · DOI
- 10.1182/blood.V88.7.2648.bloodjournal8872648 · doi:10.1182/blood.v88.7.2648.bloodjournal8872648
- 10.1128/JVI.01757-06 · DOI · Paper page
- 10.1182/blood.V86.7.2708.2708 · DOI · Paper page
- 10.1182/blood.V91.5.1671.1671_1671_1679 · doi:10.1182/blood.v91.5.1671.1671_1671_1679
- 10.1073/pnas.1002985107 · DOI
- 10.1172/JCI119380 · DOI · Paper page
- 10.1158/0008-5472.CAN-03-3835 · doi:10.1158/0008-5472.can-03-3835
- 10.1172/JCI84418 · DOI · Paper page
- 10.1128/jvi.70.11.8151-8154.1996 · DOI · Paper page
- 10.1126/science.284.5414.641 · DOI · Paper page
- 10.1172/JCI44185 · DOI
- 10.1172/JCI119804 · DOI · Paper page
- P Kellam, , Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol 1, 19–29 (1997).
- 10.1128/JVI.75.2.891-902.2001 · DOI · Paper page
- 10.1128/JVI.76.12.6213-6223.2002 · DOI · Paper page
- 10.1128/JVI.00704-09 · doi:10.1128/jvi.00704-09
- 10.1128/JVI.05071-11 · DOI
- 10.1371/journal.ppat.1002906 · doi:10.1371/journal.ppat.1002906
- 10.1074/jbc.M203489200 · doi:10.1074/jbc.m203489200
- 10.1128/JVI.77.4.2779-2783.2003 · doi:10.1128/jvi.77.4.2779-2783.2003
- 10.1128/JVI.78.22.12566-12575.2004 · doi:10.1128/jvi.78.22.12566-12575.2004
- 10.1126/science.1120541 · DOI · Paper page
- 10.1128/JVI.80.5.2243-2256.2006 · DOI
- 10.1128/JVI.00713-10 · DOI
- 10.1128/JVI.00742-14 · doi:10.1128/jvi.00742-14
- 10.1182/blood-2004-08-3052 · DOI · Paper page
- 10.1182/blood-2005-04-1627 · doi:10.1182/blood-2005-04-1627
- 10.1182/blood.V90.3.1186.1186_1186_1191 · doi:10.1182/blood.v90.3.1186.1186_1186_1191
- 10.1182/blood-2007-08-104463 · DOI
- 10.1128/JVI.79.2.1244-1251.2005 · DOI
- 10.1073/pnas.1303906110 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-0627 · doi:10.1158/0008-5472.can-08-0627
- 10.1038/313812a0 · DOI · Paper page
- 10.1371/journal.ppat.1003673 · doi:10.1371/journal.ppat.1003673
- 10.1371/journal.ppat.1003672 · doi:10.1371/journal.ppat.1003672
- 10.1073/pnas.1421804112 · DOI · Paper page
- 10.1128/JVI.01606-13 · doi:10.1128/jvi.01606-13
- 10.1128/JVI.01974-08 · doi:10.1128/jvi.01974-08
- 10.1073/pnas.0911676106 · DOI
- 10.1128/jvi.71.3.1766-1775.1997 · DOI
- 10.1186/1743-422X-7-262 · DOI
- 10.1182/blood-2003-05-1710 · doi:10.1182/blood-2003-05-1710
- 10.1038/sj.leu.2401802 · DOI
- 10.1128/JVI.78.13.7004-7015.2004 · DOI
- 10.1016/S0166-0934(00)00244-5 · DOI · Paper page
- 10.1371/journal.pone.0111502 · doi:10.1371/journal.pone.0111502
- 10.1073/pnas.1721638115 · DOI
- 10.1128/JVI.74.21.10187-10193.2000 · doi:10.1128/jvi.74.21.10187-10193.2000
- 10.1128/jvi.68.9.6069-6073.1994 · DOI · Paper page
- 10.1371/journal.ppat.1005701 · DOI · Paper page
- 10.1093/nar/gku749 · DOI · Paper page
- 10.1128/JVI.01685-13 · DOI
- 10.1128/JVI.72.2.1005-1012.1998 · DOI · Paper page
- 10.1182/blood-2010-12-323659 · DOI
- 10.1073/pnas.2336099100 · DOI · Paper page
- 10.1073/pnas.211556598 · DOI
- 10.1182/blood-2010-05-285791 · DOI
- 10.1099/0022-1317-79-6-1445 · DOI
- 10.1099/0022-1317-80-11-2889 · doi:10.1099/0022-1317-80-11-2889
- 10.1038/s41467-017-02089-9 · DOI
- 10.1371/journal.ppat.1002140 · DOI
- 10.1083/jcb.201702013 · doi:10.1083/jcb.201702013
- 10.1371/journal.pone.0010126 · DOI
- 10.1128/JCM.43.6.2866-2875.2005 · doi:10.1128/jcm.43.6.2866-2875.2005
- 10.1128/JVI.00506-13 · doi:10.1128/jvi.00506-13
- 10.1128/JVI.72.10.8143-8149.1998 · DOI
Cited by
The Global Landscape of EBV-Associated Tumors
Shannon-Lowe, C., & Rickinson, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00713 · Cited by 459
Zhou, L., Li, R., Zhang, R., Peng, R., Chen, K., Gao, P., Zhang, J., Zhang, R., & Li, J. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23256 · Cited by 4
Metadata
- Authors
- Bigi, R., Landis, J. T., An, H., Caro-Vegas, C., Raab-Traub, N., & Dittmer, D. P.
- Affiliations
- Department of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, The University of North Carolina, Chapel Hill, NC 27599
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-11-14
- Volume
- 115
- Issue
- 48
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 74
- References
- 2
- Language
- en
- Funders
- HHS | NIH | National Cancer Institute (CA019014)
- HHS | NIH | National Institute of Dental and Craniofacial Research (DE018304)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. https://app.cochat.ai/papers/10.1073/pnas.1810128115
- The paper
- Bigi, R., Landis, J. T., An, H., Caro-Vegas, C., Raab-Traub, N., & Dittmer, D. P. (2018). Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1810128115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.